Who’s really in charge when AI enters the exam room?
A new AMA framework keeps physicians at the center of AI-enabled care — but a growing body of opinion is starting to ask whether that assumption still holds
FDA clears Roche’s pTau217 blood test for Alzheimer’s amyloid assessment in primary and specialty...
A single blood draw could now replace costly imaging for millions of patients who never make it to a neurologist
Moderna and Merck’s personalized cancer vaccine hits its Phase 3 target in melanoma
A positive late-stage trial result for mRNA-based cancer immunotherapy sends Moderna's stock up nearly 150% — and raises real questions about what comes next for oncology
Innovaccer and Mastek team up to scale agentic healthcare AI across four global markets
The Platinum GSI partnership pairs Innovaccer's autonomous operations platform with Mastek's 40-year institutional footprint in the US, UK, EU, and Middle East
Epic launches one-click diagnostic image exchange across health systems
A new feature in Care Everywhere lets clinicians pull diagnostic-quality scans from outside their network instantly, ending the era of the patient-carried CD
AI demand forecasting is fixing medicine shortages in Sierra Leone
A low-cost tool built by Wharton and Penn Engineering researchers is helping Sierra Leone's government get the right drugs to the right clinics — by predicting need and cleaning up messy data
Abbott and Google Health are betting that glucose data can keep healthy people healthier
A new multi-year partnership links Abbott's Lingo CGM with Google's AI health coaching — and a large real-world metabolic study comes with it
Samsung’s Galaxy Buds just became FDA-cleared hearing aids
A software update to existing earbuds could reach more people with mild hearing loss than the entire global hearing aid market currently does
AI-generated “doctors” are racking up millions of TikTok views with fake medical advice
New research finds AI accounts spreading health misinformation at scale, and clinicians are worried about the real-world consequences
GE HealthCare bets on dense breast screening with two new ultrasound tools
Invenia ABUS Prime and browser-based viewer ABUS StreamVue aim to close a screening gap affecting 40% of women